Zobrazeno 1 - 10
of 94
pro vyhledávání: '"NanShan Zhong"'
Autor:
Nanshan Zhong, Bin Wu, Xin Du, Jinping Zheng, Li Ping Wei, Changzheng Wang, Li Zhao, David A. Lipson, Xiangdong Zhou, Bei He, Ya Dong Yuan, Jie Song
Publikováno v:
Current Medical Research and Opinion. 37:145-155
Chronic obstructive pulmonary disease (COPD) is becoming a leading cause of morbidity and mortality in China. In the IMPACT trial, fluticasone furoate[FF]/umeclidinium[UMEC]/vilanterol[VI] single-inhaler triple therapy demonstrated lower rates of mod
Autor:
Xinjie Li, Tianyu Zhang, Yaoju Tan, Nanshan Zhong, Yamin Gao, Mahmudul Islam, Lingmin Guo, Wing Wai Yew, Shouyong Tan, Shuai Wang, Xiaoyin Cai, Chiranjibi Chhotaray, Zhiyong Liu, Zhili Lu, H.M. Adnan Hameed, Xingshan Cai, Yang Liu, Jianxiong Liu
Publikováno v:
Microbial Drug Resistance. 26:766-775
Streptomycin (STR) is the first antibiotic used in the treatment of tuberculosis (TB) and the earliest antituberculosis drug with acquired resistance developed by Mycobacterium tuberculosis. The hi...
Publikováno v:
Scientific Reports, Vol 10, Iss 1, Pp 1-11 (2020)
Scientific Reports
Scientific Reports
Eosinophilic bronchitis (EB) is a clinical disease characterized by chronic cough, airway eosinophil infiltration, and responsive to steroid therapy but with the absence of airway hyperreactivity (AHR). This study established an EB mouse model with a
Autor:
Shuai Wang, Cuiting Fang, Zhiyong Liu, Wing Wai Yew, Tianyu Zhang, Mahmudul Islam, Shouyong Tan, Hm Adnan Hameed, Nanshan Zhong, Jianxiong Liu, Yaoju Tan, Zhili Lu, Chiranjibi Chhotaray
Publikováno v:
Infection and Drug Resistance. 13:217-227
Objective Pyrazinamide (PZA) is a cornerstone of modern tuberculosis regimens. This study aimed to investigate the performance of genotypic testing of pncA + upstream region, rpsA, panD, Rv2783c, and clpC1 genes to add insights for more accurate mole
Autor:
H.M. Adnan Hameed, Chiranjibi Chhotaray, Mahmudul Islam, Shouyong Tan, Jianxiong Liu, Tianyu Zhang, Zhiyong Liu, Nanshan Zhong, Yaoju Tan, Yamin Gao, Lingmin Guo, Wing Wai Yew, Shuai Wang
Publikováno v:
Journal of Thoracic Disease. 11:4613-4625
Background: Levofloxacin (LVX) and Moxifloxacin (MXF) are the cornerstones for treatment of multidrug-resistant tuberculosis (MDR-TB). China is one of the highest MDR- and fluoroquinolones (FQ)- resistant TB burdens countries. DNA gyrase encoded by g
Autor:
Xirong Tian, Shah Alam, Zhili Lu, Gift Chiwala, Nanshan Zhong, H.M. Adnan Hameed, Shuai Wang, Wei Yu, Gregory M. Cook, Tianyu Zhang, D. A. Maslov, Buhari Yusuf
Publikováno v:
Antimicrob Agents Chemother
Toxicity and inconvenience associated with the use of injectable drug-containing regimens for tuberculosis (TB) have made all-oral regimens a preferred alternative. Widespread resistance to fluoroquinolones and pyrazinamide makes it essential to iden
Autor:
Ping Guan, Julius Mugweru, Buhari Yusuf, Nanshan Zhong, Jinxing Hu, Zhiyong Liu, Yaoju Tan, Tianyu Zhang, Petuel Ndip Ndip Bate, Jianxiong Liu, Shouyong Tan, Gift Chiwala, Shahzad Akbar Khan, H.M. Adnan Hameed, Cuiting Fang, Bangxing Wang
Drug-resistant tuberculosis (DR-TB) results from infection by Mycobacterium tuberculosis strains resistant to at least rifampin or isoniazid. To improve the treatment outcome in DR-TB, therapeutic vaccines are considered an ideal choice as they can e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9ac4513fe97ec82e14463419d4c89574
https://doi.org/10.1101/2021.03.04.434024
https://doi.org/10.1101/2021.03.04.434024
Autor:
Xiaohong Xie, Wei-jie Guan, Xinqing Lin, Rongchang Chen, Zheng Zhu, Nanshan Zhong, Shiyue Li, Guoying Gao, Zhanhong Xie, Chengzhi Zhou, Ouyang Ming, Yinyin Qin
Publikováno v:
Clinical Lung Cancer. 20:e329-e337
Background Pulmonary lymphoepithelioma-like carcinoma (PLELC) is a rare subtype of lung cancer that is less reported and not well-understood. Materials and Methods We investigated the clinical features of 85 patients with PLELC to determine the progn
Autor:
Nanshan Zhong, Yanqing Xie, Jinping Zheng, Paul M. O'Byrne, Zheng Zhu, Jiaying An, Qiurong Hu, Hongyu Wang, Shu Xia, Jing Li
Publikováno v:
J Thorac Dis
BACKGROUND: Allergen nasal challenge can induce increase of eosinophils in sputum, but report about eosinophilic inflammation in upper airway after allergen bronchial challenge in Chinese asthmatics was rare. The article aims to evaluate response of
Autor:
Shaodan Wei, Yumin Zhou, Pixin Ran, Heshen Tian, Zhishan Deng, Dongxing Zhao, Peiyu Huang, Jingping Zheng, Fan Wu, Nanshan Zhong, Bijia Lin, Longhui Tang
Publikováno v:
Trials, Vol 21, Iss 1, Pp 1-10 (2020)
Trials
Trials
Introduction The presence of increased oxidative stress and airway inflammation has been proven in subjects with chronic obstructive pulmonary disease (COPD). Several studies have demonstrated that drugs with antioxidant and anti-inflammatory propert